11.17.2025
Palliative Pearls
10.21.2025
Clozapine Therapy: Overview and Place in Hospice & Palliative Care
Recently, the U.S. Food and Drug Administration (FDA) removed the Risk Evaluation and Mitigation Strategies (REMS)1 program for clozapine (Clozaril® tablets, Fazaclo® orally disintegrating tablets,...
09.23.2025
Advanced Parkinson’s Disease: Considerations for Patient Management in Transition to Hospice Services
BACKGROUND ON PARKINSON’S DISEASE Parkinson’s disease (PD) is a degenerative central nervous system disorder resulting from degeneration of dopamine-producing neurons in the section of the...
08.19.2025
A Primer on Patches: Overview of Transdermal Medication Patches in Hospice and Palliative Care
Transdermal medication patches can offer a non-invasive option of medication delivery for patients who are unable to swallow oral formulations. Several common medications for symptom...
07.22.2025
Navigating the Hospice IPU Landscape for Symptom Management
Introduction: Understanding the IPU and GIP Level of Care The Inpatient Hospice Unit (IPU) plays a pivotal role in the continuum of hospice care, providing...
06.18.2025
Approach to Blood Pressure Lowering Agents in Hospice Care
For patients with limited life expectancy, hospice goals are focused on relief of suffering through pain and symptom management rather than disease prevention, life prolongation...
05.21.2025
The Transition from HIS to HOPE: Overview and Symptom Impact Support
THE TRANSITION FROM HIS TO HOPE The Hospice Quality Reporting Program (HQRP) authorizes the Health and Human Services Secretary to establish a quality reporting program...
04.21.2025
Crushing, Opening, and Splitting Oral Dosage Forms
Crushing, opening, and splitting oral dosage forms are commonly used strategies by patients, caregivers, and healthcare professionals to address the challenges posed by dysphagia, a...
03.19.2025